# HC Wainwright

Type: Company

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/hc-wainwright-company
Canonical HTML page: https://getfinancebrief.com/entity/hc-wainwright-company

## Recent coverage (6 stories)

### IREN Drops 15% After Mixed Quarter, but $4B Run-Rate Is the Real Story
2026-08-31 00:29:52 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

IREN's 15% weekly slide looks like a reaction to legacy crypto mining revenue declines rather than a rejection of its AI cloud trajectory. With $4 billion in secured annualized run-rate revenue and sold-out 2026 capacity, the selloff may be a valuation reset for patient investors.
Full story: https://getfinancebrief.com/story/iren-stock-plunge-finance-opportunity

### NBP & CRMZ Micro-Cap Earnings: $(0.16) vs $(0.04) EPS
2026-08-22 07:00:25 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Two micro-caps reported late-August earnings: biotech I-Mab posted $(0.16) EPS while CreditRiskMonitor posted $(0.04) EPS on $5.17M revenue. Divergent risk profiles—1.47 beta vs 0.22 beta—highlight small-cap earnings dynamics.
Full story: https://getfinancebrief.com/story/imab-creditriskmonitor-microcap-earnings-comparison

### HALO stock hits $103 as FY2026 EPS guidance of $8.65-$9.00 overshoots consensus by $0.63
2026-08-12 02:50:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Halozyme Therapeutics posted a massive Q2 beat and raised FY2026 EPS guidance to $8.65-$9.00, well above the $8.02 consensus, triggering a two-day stock surge past $103. With a forward P/E near 11.5x and a PEG ratio of 0.36, the market is repricing the stock after realizing the royalty growth was underestimated.
Full story: https://getfinancebrief.com/story/halozyme-fy2026-earnings-guidance-beat-stock-surge

### TLPH Upgraded: Can $3 Target Close the 113% Gap for Talphera?
2026-08-11 12:30:02 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen’s hold upgrade caps a series of mixed analyst actions on Talphera, whose stock trades at $1.41 despite a $3.00 average target. Institutional positioning and a technical breakout suggest the market may be repricing a depressed small-cap. For investors, the gap represents both a unique opportunity and a cautionary tale of biotech volatility.
Full story: https://getfinancebrief.com/story/tlph-upgraded-113-percent-gap-finance

### HC Wainwright Cuts Circle (CRCL) to $104, Still Sees 64% Upside
2026-08-07 01:20:20 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

HC Wainwright and Needham lowered price targets on Circle Internet Group but maintained Buy ratings as analysts remain split on the stablecoin issuer. The stock trades at $63.48, far below the consensus target of $100.06, highlighting both opportunity and risk.
Full story: https://getfinancebrief.com/story/circle-crcl-price-target-cut-finance

### Flight Deck Capital Bets $10M on Hut 8 Amid Mining Sector Volatility
2026-03-16 22:50:30 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Flight Deck Capital has initiated a significant $10 million position in Hut 8 Corp., signaling institutional confidence in the miner's diversified infrastructure strategy. This move comes as the company navigates recent stock price volatility while aggressively expanding its high-performance computing and AI-ready data center footprint.
Full story: https://getfinancebrief.com/story/flight-deck-capital-hut-8-investment-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.